Earnings Miss Has Canopy Growth on the Outside Looking in

Should investors buy Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) on the dip or heed the warnings the market is putting out today?

| More on:
Cannabis stocks have fallen.
You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Canopy Growth (TSX:WEED)(NYSE:CGC) had an impressive start to the year. Indeed, Canopy Growth saw its stock price increase from under $25 per share to start the year to more than $70 per share in February. A near-tripling in approximately one month is some pretty insane momentum indeed.

However, of late, shares of Canopy are back to trading below $30 per share. Accordingly, investors looking for hyper-growth stocks at more reasonable prices may be enticed by this stock right now.

Let’s discuss why the drop has taken place and whether loading up on Canopy stock right now is a good idea.

Fourth-quarter earnings failed to meet analysts’ estimates

For companies in incredibly high-growth segments such as cannabis, quarterly earnings mean more than for, say, a company that’s been around for 100 years and is operating in a mature industry, paying a large dividend. That’s because the company’s growth trajectory matters much more to investors that anything else.

This past quarter didn’t really get investors excited. Canopy Growth reported revenue of approximately $148 million. This amounted to a 38% growth rate year over year. That’s decent but really not what investors were hoping for. On a quarter-over-quarter basis, this only amounted to a 3% increase.

Additionally, Canopy Growth’s net loss during the quarter was a whopping $616 million. That’s more than four times what the company brought in in terms of revenue.

These losses are starting to pile up, and Canopy Growth’s $1.67 billion loss for this past fiscal year highlights the profitability concern many investors have with this stock. Yes, the majority of these losses were due to asset and inventory impairment charges. However, these impairment charges indicate the company’s relatively lax capital-allocation processes.

Accordingly, Canopy Growth is now in a position where it’s focusing more on cutting costs than generating growth. This sort of a situation obviously isn’t good for long-term growth investors in such stocks.

Bottom line

Canopy Growth’s financials are finally starting to bite investors on the behind.

Indeed, this company’s growth story has been overshadowed by its poor capital-allocation choices in the past. The company projects it will burn approximately $400 million next year and $125 million in 2023. That level of cash burn means investors are likely to wait three or more years to see positive cash flow materialize. That’s a heck of a lot longer than many initially expected.

Couple this reality with the fact that U.S. legalization may take a while to materialize, if at all, and there’s a tsunami of reasons to not jump into WEED stock quite yet.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any stocks mentioned in this article.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »